115 related articles for article (PubMed ID: 8119767)
41. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women.
Vernon SD; Reeves WC; Clancy KA; Laga M; St Louis M; Gary HE; Ryder RW; Manoka AT; Icenogle JP
J Infect Dis; 1994 May; 169(5):1108-12. PubMed ID: 8169402
[TBL] [Abstract][Full Text] [Related]
42. Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa.
Verma M; Erwin S; Abedi V; Hontecillas R; Hoops S; Leber A; Bassaganya-Riera J; Ciupe SM
PLoS One; 2017; 12(1):e0168133. PubMed ID: 28060843
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology of genital human papillomavirus infection.
Koutsky L
Am J Med; 1997 May; 102(5A):3-8. PubMed ID: 9217656
[TBL] [Abstract][Full Text] [Related]
44. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
[TBL] [Abstract][Full Text] [Related]
45. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study.
Van Doornum GJ; Prins M; Juffermans LH; Hooykaas C; van den Hoek JA; Coutinho RA; Quint WG
Genitourin Med; 1994 Aug; 70(4):240-6. PubMed ID: 7959707
[TBL] [Abstract][Full Text] [Related]
46. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
Heard I; Palefsky JM; Kazatchkine MD
Antivir Ther; 2004 Feb; 9(1):13-22. PubMed ID: 15040532
[TBL] [Abstract][Full Text] [Related]
47. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
[TBL] [Abstract][Full Text] [Related]
48. Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection.
Laga M; Icenogle JP; Marsella R; Manoka AT; Nzila N; Ryder RW; Vermund SH; Heyward WL; Nelson A; Reeves WC
Int J Cancer; 1992 Jan; 50(1):45-8. PubMed ID: 1309459
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.
Dartell M; Rasch V; Munk C; Kahesa C; Mwaiselage J; Iftner T; Kjaer SK
Sex Transm Dis; 2013 Sep; 40(9):737-43. PubMed ID: 23949589
[TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.
Strickler HD; Palefsky JM; Shah KV; Anastos K; Klein RS; Minkoff H; Duerr A; Massad LS; Celentano DD; Hall C; Fazzari M; Cu-Uvin S; Bacon M; Schuman P; Levine AM; Durante AJ; Gange S; Melnick S; Burk RD
J Natl Cancer Inst; 2003 Jul; 95(14):1062-71. PubMed ID: 12865452
[TBL] [Abstract][Full Text] [Related]
51. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.
Williams AB; Darragh TM; Vranizan K; Ochia C; Moss AR; Palefsky JM
Obstet Gynecol; 1994 Feb; 83(2):205-11. PubMed ID: 8290181
[TBL] [Abstract][Full Text] [Related]
52. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.
Fakhry C; D'souza G; Sugar E; Weber K; Goshu E; Minkoff H; Wright R; Seaberg E; Gillison M
J Clin Microbiol; 2006 Dec; 44(12):4479-85. PubMed ID: 17021055
[TBL] [Abstract][Full Text] [Related]
53. [The role of some micronutrients in the evolution of HPV infection].
Atlante M; Mariani L; Luci M; Carico E; Diotallevi F; Iacovelli A; Vincenzoni C
Minerva Ginecol; 2002 Apr; 54(2):179-83. PubMed ID: 12032456
[TBL] [Abstract][Full Text] [Related]
54. HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers.
Marais DJ; Carrara H; Ramjee G; Kay P; Williamson AL
J Med Virol; 2009 Feb; 81(2):203-10. PubMed ID: 19107974
[TBL] [Abstract][Full Text] [Related]
55. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
[TBL] [Abstract][Full Text] [Related]
56. Increase of genital human papillomavirus infection among men and women in Croatia.
Grce M; Magdić L; Kocijan I; Pavelić K
Anticancer Res; 1996; 16(2):1039-41. PubMed ID: 8687096
[TBL] [Abstract][Full Text] [Related]
57. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
[TBL] [Abstract][Full Text] [Related]
58. Convergent infections: human papillomavirus and human immunodeficiency virus.
Fisher SG; Gissmann L
Antibiot Chemother (1971); 1994; 46():134-49. PubMed ID: 7826034
[No Abstract] [Full Text] [Related]
59. HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition.
Liebenberg LJP; McKinnon LR; Yende-Zuma N; Garrett N; Baxter C; Kharsany ABM; Archary D; Rositch A; Samsunder N; Mansoor LE; Passmore JS; Abdool Karim SS; Abdool Karim Q
Nat Commun; 2019 Nov; 10(1):5227. PubMed ID: 31745084
[TBL] [Abstract][Full Text] [Related]
60. HPV infections and immunosuppression.
Bouwes Bavinck JN; Berkhout RJ
Clin Dermatol; 1997; 15(3):427-37. PubMed ID: 9255448
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
